Project Grant SB1AA033292
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Mountain View, CA 94043, USA
Similar Awards
- Federal Project Grant Summary Small Molecule Modulators of RXFP3 for Alcohol Use Disorder Research Triangle Institute (RTI International) received a $1.76 million Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to develop novel therapeutic compounds for alcohol use disorder (AUD) treatment. Awarded on September 20, 2025, and scheduled for completion by June 30, 2030, this project focuses on optimizing...
- Federal Project Grant Award Summary Ubiquitx Inc. received a $391,495 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) awarded August 15, 2025, with a completion date of July 31, 2027. The company is developing and testing deubiquitinating Chimeric Ligands for Induced Proximity (DubCLIPs) as part of its Phase I Small Business Innovation Research (SBIR) initiative. This platform technology uses computationally...
- Grant Summary RTI International (Research Triangle Institute) received a $1.12 million Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) effective September 1, 2025, through June 30, 2030. The award supports multi-omic data integration research aimed at discovering neurobiological factors underlying alcohol use disorder (AUD) with and without cigarette smoking comorbidity. The research investigates AUD-associated...
- Federal Grant Award Summary Texas Tech University Health Sciences Center (TTUHSC) received a Project Grant award of $222,813 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 1, 2025, with completion anticipated by August 31, 2027. The research addresses the critical need for novel therapeutic targets in Alcohol Use Disorder (AUD) treatment by investigating the role of endogenous retroviruses...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded Palo Alto Veterans Institute for Research a $1.09 million Project Grant (CFDA 93.273 – Alcohol Research Programs) on September 20, 2025, with completion expected by June 30, 2030. This mechanistic clinical trial will assess the efficacy of deep transcranial magnetic stimulation (DTMS) as a neuromodulation treatment for alcohol use disorder (AUD) by evaluating whether active DTMS targeting the...
- Federal Project Grant Award Summary EnvisBio LLC received a $390,454 Phase I Small Business Innovation Research (SBIR) grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to develop aptamer-based therapeutic candidates targeting phosphodiesterase 4B (PDE4B) for treating alcohol use disorder (AUD). Awarded on September 15, 2025, with completion targeted for August 31, 2027, this project addresses the significant public health...
- Federal Grant Award Summary Yale University received a $440,566 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), awarded September 16, 2025, with a completion date of August 31, 2027. The grant funds research to advance treatment of alcohol-associated liver disease (ALD) through precision targeting of methyltransferase-like (METTL) protein family members, specifically METTL7A. The project will deliver mechanistic...
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. (Boston, MA) received a $2.07 million Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) effective September 15, 2025, with completion targeted for May 31, 2030. The research project, titled "Innate Immune Dysregulation in Alcohol-Associated Liver Disease," investigates the mechanisms underlying alcohol-associated hepatitis...
- Federal Project Grant Award Summary BD Holding, Inc. received a $406,412 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), awarded August 15, 2025, with completion targeted for July 31, 2027. The awardee is developing and validating an epigenetic diagnostic tool called the Alcohol T Score (ATS) to quantify steady-state alcohol consumption and assess its relationship to coronary heart disease (CHD) risk. The...
- Federal Project Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $596,476 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) effective May 1, 2026, through February 28, 2031. The project investigates the role of acute phase response (APR) signaling in alcohol-associated liver disease (ALD) resolution following alcohol cessation. The research aims to elucidate...